ATE365728T1 - Ecstasy-derivate, immunogene und antikörper sowie deren verwendung zum nachweis von ecstasy-artigen drogen - Google Patents

Ecstasy-derivate, immunogene und antikörper sowie deren verwendung zum nachweis von ecstasy-artigen drogen

Info

Publication number
ATE365728T1
ATE365728T1 AT04016651T AT04016651T ATE365728T1 AT E365728 T1 ATE365728 T1 AT E365728T1 AT 04016651 T AT04016651 T AT 04016651T AT 04016651 T AT04016651 T AT 04016651T AT E365728 T1 ATE365728 T1 AT E365728T1
Authority
AT
Austria
Prior art keywords
ecstasy
immunogens
antibodies
derivatives
detecting
Prior art date
Application number
AT04016651T
Other languages
English (en)
Inventor
Mitali Ghoshal
Gerald F Sigler
Richard Terry Root
Anlonga Ouyang
Salvatore J Salamone
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE365728T1 publication Critical patent/ATE365728T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/946CNS-stimulants, e.g. cocaine, amphetamines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT04016651T 2003-07-18 2004-07-15 Ecstasy-derivate, immunogene und antikörper sowie deren verwendung zum nachweis von ecstasy-artigen drogen ATE365728T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/622,254 US7060847B2 (en) 2003-07-18 2003-07-18 Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs

Publications (1)

Publication Number Publication Date
ATE365728T1 true ATE365728T1 (de) 2007-07-15

Family

ID=33477128

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04016651T ATE365728T1 (de) 2003-07-18 2004-07-15 Ecstasy-derivate, immunogene und antikörper sowie deren verwendung zum nachweis von ecstasy-artigen drogen

Country Status (7)

Country Link
US (2) US7060847B2 (de)
EP (1) EP1498415B1 (de)
JP (1) JP4369814B2 (de)
AT (1) ATE365728T1 (de)
CA (1) CA2473596C (de)
DE (1) DE602004007200T2 (de)
ES (1) ES2289399T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050130243A1 (en) * 2003-12-15 2005-06-16 Zheng Yi F. Assay for entactogens
US7294649B2 (en) * 2004-12-17 2007-11-13 Roche Diagnostics Operatins, Inc. Methamphetamine derivatives and conjugates for immunoassay
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
WO2008016677A2 (en) * 2006-08-02 2008-02-07 Auspex Pharmaceuticals, Inc. Preparation and utility of deuterated amphetamines
KR20240045222A (ko) * 2021-07-07 2024-04-05 테란 바이오사이언시스 인코포레이티드 3,4-메틸렌다이옥시메스암페타민 및 관련 환각제, 그리고 이들의 용도
US20230202998A1 (en) 2021-11-17 2023-06-29 Terran Biosciences, Inc. Phenethylamine compounds salts, polymorphic forms and methods of use thereof
CA3218730A1 (en) * 2022-02-28 2023-08-31 Denton W. Hoyer Novel prodrug compounds of 3,4-methylenedioxymethamphetamine (mdma) and methods of synthesizing the same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041076A (en) 1974-10-23 1977-08-09 Hoffmann-La Roche Inc. Immunoassay for pharmacologically active phenethylamines
JPH01211582A (ja) 1988-02-16 1989-08-24 Tanabe Seiyaku Co Ltd ベンゾジオキソール誘導体
DE69030829T2 (de) 1989-03-10 1998-01-15 Hoffmann La Roche Reagenzien zum Nachweis von Drogen
EP0471515B1 (de) * 1990-08-15 1997-03-05 Eli Lilly And Company Ring-substituierte 2-Amino-1,2,3,4-tetra-hydronaphthaline, 3-Aminochromane und 3-Aminothiochromane
US5470997A (en) 1992-04-06 1995-11-28 Biosite Diagnostics Incorporated Amphetamine derivatives and protein and polypeptide amphetamine derivative conjugates and labels
CA2096495C (en) 1992-06-16 2002-07-09 Kathy Palmer Ordonez Dual analyte immunoassay
DE19630102A1 (de) 1996-07-25 1998-01-29 Boehringer Mannheim Gmbh Neue aktivierte Amphetamine
GB2361473C (en) * 2000-03-08 2005-06-28 Microgenics Corp Ecstasy-class analogs and use of same in detection of ecstasy-class compounds
US6534325B1 (en) * 2000-06-30 2003-03-18 Roche Diagnostics Corporation Immunoassay for the detection of amphetamines, methamphetamines and methylenedioxy designer amphetamines
ATE408843T1 (de) * 2001-12-20 2008-10-15 Randox Lab Ltd Verfahren und kit zum nachweis oder zur bestimmung von 3,4-methylendioxymethamphetamin
US7169907B2 (en) * 2002-03-01 2007-01-30 Roche Diagnostics Operations, Inc. Derivatives, immunogens, and antibodies for detecting ecstasy-class drugs

Also Published As

Publication number Publication date
CA2473596C (en) 2008-09-30
CA2473596A1 (en) 2005-01-18
DE602004007200T2 (de) 2008-02-28
DE602004007200D1 (de) 2007-08-09
US20050153439A1 (en) 2005-07-14
US20050014210A1 (en) 2005-01-20
EP1498415A1 (de) 2005-01-19
JP2005097252A (ja) 2005-04-14
ES2289399T3 (es) 2008-02-01
US7569676B2 (en) 2009-08-04
EP1498415B1 (de) 2007-06-27
JP4369814B2 (ja) 2009-11-25
US7060847B2 (en) 2006-06-13

Similar Documents

Publication Publication Date Title
DE60330015D1 (de) Aza-bicycloalkylether und deren verwendung als alpha7-nachr agonisten
CY1119077T1 (el) Παραγωγα πυραζολυλαμινοπυριδινης χρησιμα ως αναστολεις κινασων
EA200701121A1 (ru) Потенциаторы рецепторов глутамата
CY1109593T1 (el) Παραγωγα 12,13-κυκλοπροπανο εποθιλονης
CY1111884T1 (el) Μονοκλωνικο αντισωμα αντι-met, θραυσματα και κομιστες αυτου, για την αγωγη νεοπλασιων και αντιστοιχα προϊοντα
DE502006004453D1 (de) Benzo (d) isoxazol-3-yl-amin- verbindungen und deren verwendung als vanilloid-rezeptor liganden
CY1108041T1 (el) Αναστολεις της rho-κινασης
CY1108754T1 (el) Νεα παραγωγα θειοφαινογλυκοσιδης, μεθοδος για την παρασκευη τους, φαρμακα περιεχοντα αυτες τις ενωσεις και η χρηση τους
BR0315161A (pt) Anticorpo isolado, polinicleotìdeo isolado, vetor, célula hospedeira, método de produzir um anticorpo, e, composição
CY1113224T1 (el) Νεο αντισωμα αντι-ρlgf
SI1557462T1 (sl) Celice monocitnega izvora, ki inducirajo sprejemljivost transplantata, kot tudi njihova priprava in uporaba
CY1107339T1 (el) Mu-1, μελος της οικογενειας υποδοχεα κυτοκινης
DE602004007200D1 (de) Ecstasy-Derivate, Immunogene und Antikörper sowie deren Verwendung zum Nachweis von Ecstasy-artigen Drogen
DK1875237T3 (da) Docetaxel-immunassay
CA2419696A1 (en) Compounds, antibodies, reagent kits, methods of producing antibodies, and methods of detecting analytes
DK0956286T3 (da) Syntese af terfenadin og derivater deraf
ATE426172T1 (de) Zusammensetzungen und verfahren zum nachweis von ehrlichia canis- und ehrlichia chaffeensis- antikírpern
BR0312863A (pt) Derivados de aldeìdo de polietileno glicol
CA2473759A1 (en) Antibodies for detecting ecstasy-class analytes
ATE538119T1 (de) Benzothiazolcyclobutylamin-derivate und deren verwendung als histamin-3-rezeptor-liganden
ATE474226T1 (de) Taxol-immunoassay
DE60226428D1 (de) DIHYDROIMIDAZOi4,5-E INDOL- UND 7H-PYRROLOi3,2-F CHINOXALINDERIVATE ALS NIKOTIN-ACETYLCHOLIN-REZEPTORLIGANDEN UND/ODER SEROTONERGISCHE LIGANDEN
DE602004021567D1 (de) Antikörper gegen tumorspezifisches antigen als ziel
ATE390427T1 (de) Diazabicylononan - und decanderivate und ihre verwendung als opioid-rezeptorligande
ATE497947T1 (de) Neue 1,3-disubstituierte azetidinderivate zur verwendung als liganden des 5ht2a-rezeptors

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1498415

Country of ref document: EP